Basalt, CO, United States of America

Doug Dolginow

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Doug Dolginow: Innovator in Personalized Medicine

Introduction

Doug Dolginow is a prominent inventor based in Basalt, CO (US). He has made significant contributions to the field of personalized medicine, holding a total of 7 patents. His work focuses on utilizing molecular markers to enhance treatment regimens for patients, thereby improving healthcare outcomes.

Latest Patents

Among his latest patents, Doug has developed methods for sequencing samples that are crucial for personalized medicine. These methods leverage a patient's molecular markers to guide treatment regimens effectively. The scientific literature highlights numerous correlations between drug treatment efficacy and the presence or absence of these molecular markers in patient samples. His innovative methods facilitate the efficient dissemination of scientific findings regarding treatment efficacy and the molecular markers found in patient tumors to healthcare providers.

Career Highlights

Throughout his career, Doug has worked with notable companies such as Aqtual, Inc. and Toma Biosciences, Inc. His experience in these organizations has allowed him to refine his expertise in the field of personalized medicine and contribute to groundbreaking advancements.

Collaborations

Doug has collaborated with esteemed professionals in the industry, including Dietrich Stephan and Vern Norviel. These partnerships have further enriched his work and expanded the impact of his innovations.

Conclusion

Doug Dolginow's contributions to personalized medicine through his patents and collaborations underscore his role as a leading inventor in the field. His work continues to influence healthcare practices and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…